🔎 Trials Near Me

Beranda › Lupus › Florida

Uji klinis Lupus di Florida

23 studi untuk Lupus mencari peserta di lokasi di Florida.

Kota di Florida

Teks studi resmi (Bahasa Inggris)

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

  • Sl0044 50239, Brandon
  • Sl0044 50630, Clearwater
  • Sl0044 50751, Coral Gables
  • dan 9 lainnya
Menerima pesertaFase 3
Usia 16 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06617325

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

  • Royal Research Corp, Hollywood
  • Florida Kidney Physicians, Riverview
  • Florida Kidney Physicians, Riverview
Menerima pesertaFase 2
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05268289

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

  • AARDS Research, Inc., Aventura
  • Meris Clinical Research-Brandon-69466, Brandon
  • Clinical Research of West Florida, Inc., Clearwater
  • dan 2 lainnya
Menerima pesertaFase 2
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07409181

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

  • Clinical Res Of W Florida, Clearwater
  • GNP Research, Cooper City
  • Homestead Assoc In Research Inc, Homestead
  • dan 2 lainnya
Menerima pesertaFase 3
Usia 12 hingga 100 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06133972

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

  • Research Site, Brandon
  • Research Site, Miami
  • Research Site, Miami
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07430306

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

  • Arthritis & Rheumatic Disease Specialties, Aventura
  • Clinical Research of West Florida 1, Clearwater
  • Avanti Clinical Research Corp, Hialeah
  • dan 5 lainnya
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07438496

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

  • Clinical Research Of West Florida - Phase I Unit /ID# 279292, Clearwater
  • Finlay Medical Research - Greenacres /ID# 278380, Greenacres City
  • Clinical Research of Osceola /ID# 278374, Kissimmee
  • dan 3 lainnya
Menerima pesertaFase 1
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07607964

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

  • Research Site, Plantation
Menerima pesertaFase 1
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07201558

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

  • Omega Research Debary, LLC, DeBary
  • South Florida Rheumatology, Hollywood
  • GTL Medical And Research Group, Miami
  • dan 2 lainnya
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07355218

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

  • GNP Research, Cooper City
  • University of Florida Clinical Research Center, Gainesville
  • Miami Dermatology and Laser Research, Miami
  • dan 1 lainnya
Menerima pesertaFase 2
Usia 12 hingga 70 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07570862

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

  • GNP Research at Mark Jaffe, MD, Cooper City
  • Advance Medical Research Center, Miami
  • Diverse Clinical Research LLC, Miami
  • dan 2 lainnya
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07332481

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Mayo Clinic, Jacksonville
Menerima pesertaFase 1
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07085104

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

  • Centre for Rheumatology, Immunology and Arthritis, Fort Lauderdale
  • South Florida Rheumatology, Hollywood
  • LIFE Clinical Trials, Margate
  • dan 1 lainnya
Menerima pesertaStudi observasional
Usia 16 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07175285

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

  • Mayo Clinic, Jacksonville
Menerima pesertaFase 1/2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06121297

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

  • Bioresearch Partner Coral Terrace, South Miami
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT06570798

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)

  • Highlands Advanced Rheumatology And Arthritis Center - Avon Park /ID# 278239, Avon Park
  • Clinical Research Of West Florida - Phase I Unit /ID# 275834, Clearwater
  • Life Clinical Trials - Colonial Drive - Margate /ID# 276050, Margate
  • dan 1 lainnya
Menerima pesertaFase 1
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT06977724

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

  • Dolphin Medical Research, Doral
  • Alloy Clinical Research LLC, Kissimmee
  • SouthCoast Research Center, Miami
  • dan 4 lainnya
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT07201129

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

  • Investigative Site, Clearwater
  • Investigative Site, DeBary
  • Investigative Site, Tampa
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT07260877

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

  • Omega Research Group, Orlando
Menerima pesertaFase 1
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 5 Jun 2026 · NCT06613360

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

  • US03-0, Clearwater
  • US05-0, Orlando
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 2 Jun 2026 · NCT06625671

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

  • University of Florida, Gainesville
  • Nicklaus Children's Hospital, Miami
Menerima pesertaFase 1
Usia 12 hingga 70 · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT06308978

Lupus Landmark Study: A Prospective Registry and Biorepository

  • University of Miami, Miami
Menerima pesertaStudi observasional
Usia 18 hingga 110 · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT05934149

Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.

  • IRIS Research and Development, LLC, Plantation
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2024 · NCT06581562

Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.